U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H21FN2O4S
Molecular Weight 416.466
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RAMATROBAN

SMILES

OC(=O)CCN1C2=C(C[C@@H](CC2)NS(=O)(=O)C3=CC=C(F)C=C3)C4=C1C=CC=C4

InChI

InChIKey=LDXDSHIEDAPSSA-OAHLLOKOSA-N
InChI=1S/C21H21FN2O4S/c22-14-5-8-16(9-6-14)29(27,28)23-15-7-10-20-18(13-15)17-3-1-2-4-19(17)24(20)12-11-21(25)26/h1-6,8-9,15,23H,7,10-13H2,(H,25,26)/t15-/m1/s1

HIDE SMILES / InChI

Molecular Formula C21H21FN2O4S
Molecular Weight 416.466
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Ramatroban is a dual antagonist of thromboxane A2 receptor and PGD2 receptor. The drug was developed by Bayer and tested for the treatment of asthma and allergic rhinitis. In Japan ramatroban reached final approval and is being marketed under the name Baynas. In vitro studies have shown that the drug effectively inhibits smooth muscle cells contraction.

CNS Activity

Curator's Comment: Ramatroban and its labeled metabolites did hardly penetrate the blood-brain barrier.

Originator

Curator's Comment: # Bayer

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
BAYNAS

Approved Use

Treatment of Allergic rhinitis.

Launch Date

9.5264637E11
PubMed

PubMed

TitleDatePubMed
Differential effects of prostacyclin and iloprost in the isolated carotid artery of the guinea-pig.
2001 Aug 24
Participation of chemical mediators other than histamine in nasal allergy signs: a study using mice lacking histamine H(1) receptors.
2002 Aug 9
Participation of chemical mediators in the development of experimental allergic conjunctivitis in rats.
2004 Nov
Patents

Patents

Sample Use Guides

75 mg is administered orally devided in two doses, after breakfast and after dinner (or before going to bed).
Route of Administration: Oral
In Vitro Use Guide
Human airway smooth muscle preparations and lung strips were treated wuth 10(-6), 10(-7) and 10(-8) M of remetroban to inhibit U46619-induced contractions.
Substance Class Chemical
Created
by admin
on Thu Jul 06 23:09:50 UTC 2023
Edited
by admin
on Thu Jul 06 23:09:50 UTC 2023
Record UNII
P1ALI72U6C
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RAMATROBAN
INN   JAN   MART.   MI   WHO-DD  
INN  
Official Name English
RAMATROBAN [JAN]
Common Name English
EN-137774
Code English
BAYNAS
Brand Name English
RAMATROBAN [MART.]
Common Name English
(+)-(3R)-3-(P-FLUOROBENZENESULFONAMIDO)-1,2,3,4-TETRAHYDROCARBAZOLE-9-PROPIONIC ACID
Systematic Name English
(3R)-3-(((4-FLUOROPHENYL)SULFONYL)AMINO)-1,2,3,4-TETRAHYDRO-9H-CARBAZOLE-9-PROPANOIC ACID
Systematic Name English
RAMATROBAN [MI]
Common Name English
9H-CARBAZOLE-9-PROPANOIC ACID, 3-(((4-FLUOROPHENYL)SULFONYL)AMINO)-1,2,3,4-TETRAHYDRO-, (3R)-
Systematic Name English
ramatroban [INN]
Common Name English
Ramatroban [WHO-DD]
Common Name English
BAY-U-3405
Code English
Classification Tree Code System Code
NCI_THESAURUS C1327
Created by admin on Thu Jul 06 23:09:50 UTC 2023 , Edited by admin on Thu Jul 06 23:09:50 UTC 2023
Code System Code Type Description
INN
7273
Created by admin on Thu Jul 06 23:09:50 UTC 2023 , Edited by admin on Thu Jul 06 23:09:50 UTC 2023
PRIMARY
EVMPD
SUB10245MIG
Created by admin on Thu Jul 06 23:09:50 UTC 2023 , Edited by admin on Thu Jul 06 23:09:50 UTC 2023
PRIMARY
MESH
C063119
Created by admin on Thu Jul 06 23:09:50 UTC 2023 , Edited by admin on Thu Jul 06 23:09:50 UTC 2023
PRIMARY
FDA UNII
P1ALI72U6C
Created by admin on Thu Jul 06 23:09:50 UTC 2023 , Edited by admin on Thu Jul 06 23:09:50 UTC 2023
PRIMARY
WIKIPEDIA
Ramatroban
Created by admin on Thu Jul 06 23:09:50 UTC 2023 , Edited by admin on Thu Jul 06 23:09:50 UTC 2023
PRIMARY
DRUG BANK
DB13036
Created by admin on Thu Jul 06 23:09:50 UTC 2023 , Edited by admin on Thu Jul 06 23:09:50 UTC 2023
PRIMARY
ChEMBL
CHEMBL361812
Created by admin on Thu Jul 06 23:09:50 UTC 2023 , Edited by admin on Thu Jul 06 23:09:50 UTC 2023
PRIMARY
DRUG CENTRAL
2354
Created by admin on Thu Jul 06 23:09:50 UTC 2023 , Edited by admin on Thu Jul 06 23:09:50 UTC 2023
PRIMARY
MERCK INDEX
M9488
Created by admin on Thu Jul 06 23:09:50 UTC 2023 , Edited by admin on Thu Jul 06 23:09:50 UTC 2023
PRIMARY
EPA CompTox
DTXSID1046685
Created by admin on Thu Jul 06 23:09:50 UTC 2023 , Edited by admin on Thu Jul 06 23:09:50 UTC 2023
PRIMARY
NCI_THESAURUS
C76400
Created by admin on Thu Jul 06 23:09:50 UTC 2023 , Edited by admin on Thu Jul 06 23:09:50 UTC 2023
PRIMARY
SMS_ID
100000080311
Created by admin on Thu Jul 06 23:09:50 UTC 2023 , Edited by admin on Thu Jul 06 23:09:50 UTC 2023
PRIMARY
CAS
116649-85-5
Created by admin on Thu Jul 06 23:09:50 UTC 2023 , Edited by admin on Thu Jul 06 23:09:50 UTC 2023
PRIMARY
PUBCHEM
123879
Created by admin on Thu Jul 06 23:09:50 UTC 2023 , Edited by admin on Thu Jul 06 23:09:50 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY